Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer

Journal of Pain and Symptom Management

Volumn 41, Issue 4, 2011, Pages 788-795

  Dev, Rony ^a   Hui, David ^a   Dalal, Shalini ^a   Nooruddin, Zohra I ^a   Yennurajalingam, Sriram ^a   Del Fabbro, Egidio ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cortisol; opioid therapy; testosterone

Indexed keywords

HYDROCORTISONE; MORPHINE; OPIATE; TESTOSTERONE;

ADULT; ADVANCED CANCER; AGED; ANXIETY; ANXIETY DISORDER; ARTICLE; CACHEXIA; CAUCASIAN; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DATA COLLECTION METHOD; DEPRESSION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISTRESS SYNDROME; FATIGUE; FEMALE; GONAD FUNCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; PAIN; RETROSPECTIVE STUDY; SYMPTOM DISTRESS SCALE; TESTOSTERONE BLOOD LEVEL; THORAX CANCER;

AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PAIN MEASUREMENT; PAIN, INTRACTABLE; RETROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 79954417991     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2010.06.021     Document Type: Article

References (30)

1. A. Pfeiffer, and A. Herz Endocrine actions of opioids Horm Metab Res 16 1984 386 397 (Pubitemid 14095804)
2. A. Rajagopal, R. Vassilopoulou-Sellin, J.L. Palmer, G. Kaur, and E. Bruera Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids Cancer 100 2004 851 858 (Pubitemid 38176866)
3. K. Mussig, D. Knasu-Dittmann, and H. Schmidt Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment Clin Endocrinol (Oxf) 66 2007 602 605
4. R. Salvatori Adrenal insufficiency JAMA 294 2005 2481 2498
5. K.M. Oltmanns, H.L. Fehm, and A. Peters Chronic fentanyl application induces adrenocortical insufficiency J Intern Med 257 2005 478 480 (Pubitemid 40604552)
6. R.T. Chlebowski, and D. Heber Hypogonadism in male patients with metastatic cancer prior to chemotherapy Cancer Res 42 1982 2495 2498 (Pubitemid 12121481)
7. D.M. Greenfield, S.J. Walters, and R.E. Coleman Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study J Clin Endocrinol Metab 92 2007 3476 3482 (Pubitemid 47435323)
8. F. Crasser, J.L. Palmer, and L.R. Schover The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study Cancer 107 2006 2949 2957 (Pubitemid 44937051)
9. V.T. Chang, S.S. Hwang, and M. Feruerman Validation of the Edmonton Symptom Assessment Scale Cancer 88 2000 2164 2171 (Pubitemid 30233220)
10. C. Rivier, J. Rivier, and W. Vale Stress-induced inhibition of reproductive functions: role of endogenous corticotrophin-releasing factor Science 231 1986 607 609 (Pubitemid 16088944)
11. K.E. Nikolarakis, O.F.X. Almedia, and A. Herz Corticotropin-releasing factor (CRH) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro Brain Res 377 1986 388 390 (Pubitemid 16041297)
12. O.F.X. Almeida, K.E. Nikolarakis, and A. Herz Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotrophin releasing factor Endocrinology 122 1988 1034 1041 (Pubitemid 18082063)
13. F. Petraglia, W. Vale, and C. Rivier Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat Endocrinology 119 1986 2445 2450 (Pubitemid 17193104)
14. A. Grossman, P.J. Moult, D. Cunnah, and M. Besser Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man Neuroendocrinology 42 1986 357 360 (Pubitemid 16126943)
15. D.G. Pfeiffer, A. Pfeiffer, Y. Shimohigashi, G.R. Merriam, and D.L. Loriaux Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion Peptides 4 1983 647 649 (Pubitemid 14223707)
16. M. Hoehe, T. Duka, and A. Doenicke Human studies on the μ opiate receptor agonist fentanyl: neuroendocrine and behavioral responses Psychoneuroendocrinology 13 1988 397 408
17. A. Pende, N.R. Musso, and M.L. Montaldi Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men Biomed Pharmacother 40 1986 178 182 (Pubitemid 16031027)
18. E. Ur, D.M. Wright, P.M.G. Bouloux, and A. Grossman The effects of spiradoline (U-62066E), a κ-opioid receptor agonist, on neuroendocrine function in man Br J Pharmacol 120 1997 781 784 (Pubitemid 27122716)
19. B.G. Redman, R. Pazdur, A.P. Zingas, and R. Loredo Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis Cancer 60 1987 103 107 (Pubitemid 17083559)
20. S. Palm, H. Moenig, and C. Maier Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis Methods Find Exp Clin Pharmacol 19 1997 269 273 (Pubitemid 27286094)
21. R.I. Dorin, C.R. Qualls, and L.M. Crapo Diagnosis of adrenal insufficiency Ann Intern Med 139 2003 194 204 (Pubitemid 38124602)
22. E. Ozyuvaci, N.Y. Aligenis, and A. Altan The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain J Pain Symptom Manage 28 2004 277 281 (Pubitemid 39158811)
23. F. Tennant, and L. Hermann Normalization of serum cortisol concentration with opioid treatment of severe chronic pain Pain Med 3 2002 132 134
24. H. Daniell Opioid contribution to decreased cortisol levels in critical care patients Arch Surg 143 2008 1147 1148
25. H. Iwagaki, A. Hizuta, and M. Uomoto Cancer cachexia and depressive states: a neuro-endocrine-immunological disease? Acta Med Okayama 51 1997 233 236 (Pubitemid 127457694)
26. C. Drott, G. Svaninger, and K. Lundholm Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients Ann Surg 208 1988 645 650 (Pubitemid 18267709)
27. S. Lundstrom, and C.J. Furst Symptoms in advanced cancer: relationship to endogenous cortisol levels Palliat Med 17 2003 503 508 (Pubitemid 37160889)
28. G. Mazzoccoli, S. Carughi, A. De Cata, M. La Viola, and G. Vendemiale Melatonin and cortisol serum levels in lung cancer patients at different stages of disease Med Sci Monit 11 2005 284 288
29. R.J. Schaur, H.J. Semmelrock, E. Schauensten, and L. Kronberger Tumor host relations. II. Influence of tumor extent and tumor site on plasma cortisol of patients with malignant diseases J Cancer Res Clin Oncol 93 1979 287 292 (Pubitemid 9161039)
30. D.G. Cruess, M.H. Antoni, and B.A. McGregor Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer Psychosom Med 62 2000 304 308 (Pubitemid 30347072)